switching from tirzepatide to semaglutide dosing Semaglutide: What to Expect transitioning from semaglutide to tirzepatide

Flynn McGuire, Assistenzarzt fr Physikalische Medizin und Rehabilitation an der University of Utah, der im Frhjahr 2024 erstmals auf die Substanz stie

Recent Major Changes Indications and Usage for Zepbound ZEPBOUND is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition

Plateaus are normal and do not indicate treatment failure

Medical treatment for medical conditions is standard care, not shortcut